ERG Components in Schizophrenia and Bipolar Disorder Type I
common.study.values.description
“ERG Components in Schizophrenia and Bipolar Disorder Type I”
This study will further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis. The prediction models are diaMentis proprietary software used as an ERG-based diagnostic test (classified as a Software as Medical Device, SaMD) to support the diagnosis of schizophrenia and bipolar disorder type I. They involve the processing and analysis of specific retinal biosignatures (RSPA) with the support of statistical and mathematical modelling processes e.g. machine learning and statistical learning.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Device - ERG assessment (RSPA)
Processing and analysis of retinal signals
participant.views.study.view.additional
participant.views.study.view.scientific-title
Assessment of ERG Components to Discriminate Between Schizophrenia and Bipolar Disorder Type I
common.study.values.clinical-trial-id
NCT03788811
participant.views.study.view.id
e73Owe
